Release of Hepatic Stimulatory Substance from Cultures of Free and Microencapsulated Hepatocytes: Preliminary Report
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Biomaterials, Artificial Cells and Artificial Organs
- Vol. 16 (4) , 741-746
- https://doi.org/10.3109/10731198809117566
Abstract
The galactosamine induced liver failure animal model was used to study the release of hepatic stimulatory substance (HSS) from free and microencapsulated hepatocytes in culture. Free hepatocyte cultures released HSS which significantly increased DNA synthesis in hepatocyte and the survival time of this animal model. The release HSS was not observed when hepatocytes were microencapsulated in an alginate matrix. The alginate matrix has a pore size which does not allow molecules larger than albumin (64,000 M.W.) to pass through the matrix. This suggests that of the two different ranges of molecular weights suggested for the hepatic stimulatory substance, those in the higher molecular range are important for liver regeneration.This publication has 5 references indexed in Scilit:
- Purification and physical-chemical characterization of hepatic stimulator substance†Hepatology, 1987
- Human serum does contain a high molecular weight hepatocyte growth factor: Studies pre- and post-hepatic resectionBiochemical and Biophysical Research Communications, 1986
- Optimization of microencapsulation parameters: Semipermeable microcapsules as a bioartificial pancreasBiotechnology & Bioengineering, 1985
- CONTROL OF HEPATOCYTE REPLICATION BY 2 SERUM FACTORS1984
- Use of 3H-thymidine for measurement of DNA synthesis in rat liver—a warningAnalytical Biochemistry, 1972